Former WHO scientist Dr Soumya Swaminathan has warned that rising pollution in North India poses serious health risks to ...

A 19-year single-center study of 516 glioma patients, validated in three public cohorts, shows that high KCNJ11 mRNA ...

KARI's multimodal imaging dataset reveals critical insights into Alzheimer's disease, linking amyloid, tau, and brain ...

In a cross-sectional study of 59 people with asymptomatic moyamoya disease, DTI-ALPS was more consistently associated with ...

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor ...

This week, topics ranged from brain signals and immune cells to gene delivery therapies. All of these are summaries of ...

Dominic Gillen has been fighting for years to get his son access to medical marijuana in Nebraska. He believes it could help ...

GSK presents first global data for Ris-Rez in extensive-stage small cell lung cancer. 61% overall response rate in phase Ib trial; Results buil ...

Introduction"Learning a foreign language makes you smarter"—this claim is encountered in various settings, from ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

Optogenetic therapy improved clinically meaningful light sensitivity in 6 of 10 people with advanced retinitis pigmentosa in an early-stage clinical study.

Investigators will share detailed findings from the phase 1a/b EMBOLD PanTumour-101 study at the European Society for Medical ...